Money for nothing? Risks in biopharmaceutical companies from the perspective of public financiers

Author: Heinonen Laura   Sandberg Birgitta  

Publisher: Palgrave Macmillan Ltd

ISSN: 1478-565X

Source: Journal of Commercial Biotechnology, Vol.14, Iss.4, 2008-10, pp. : 287-298

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract